Egg Freezing and Embryo Banking Market – By Service Type, By Storage Duration, By Technology, By Application, By Age Group - Global Forecast, 2024 – 2032

Egg Freezing and Embryo Banking Market Size

The global egg freezing and embryo banking market was estimated at USD 4.3 billion in 2023. The market is expected to grow from USD 4.7 billion in 2024 to USD 9.9 billion in 2032, at a CAGR of 9.8% during the forecast period. The market refers to the technologies and services dedicated for freezing or cryopreservation of the egg cells (Oocytes) and embryos for the future use. This market involves various facilities that support couples and individuals looking to preserve fertility for various reasons, including family planning flexibility, medical treatment, or for age- related fertility decline.
 

The growth of the market is largely accelerated by the rising rate of infertility among the individuals globally. Infertility is a complex medical concern that is affecting larger pool of individuals globally. For instance, as per the data from the World Health Organization (WHO), 17.5% of the adult population across the world experiences infertility in their lifetime, which is equivalent to 1 in 6 individuals.
 

Moreover, according to the 2025 study published in the Journal of Human reproduction, in 2021, around 55,000,818 men and 110,089,459 women globally were living with infertility, equating to 1,820.6 cases of males and 3,713.2 cases of female per 100,000 population. This alarming statistic underscores the demanding need for effective, accessible, and top tier fertility preservation solutions, such as egg freezing and embryo banking, in order the combat infertility related complications among the couples and individual across the globe.
 

Additionally, advancement in the cryopreservation technology is a significant catalyst for the growth of the market. Innovation in the cryopreservation techniques such ultra-rapid freezing, vitrification, among others is expanding the success rate of fertility preservation and propelling the positive reproductive outcome. For instance, as per the studies, the post thawing survival rate of egg and embryo is approximately 90% when the egg and embryo were frozen by the advanced vitrification technology. Thus, the high success and survival rate offered by this advanced technology, stimulating the adoption of fertility preservation methods such as egg freezing and embryo banking among the individuals and couple looking to preserve the fertility, thereby fostering the market growth.
 

Egg Freezing and Embryo Banking Market Trends

• The rising awareness and acceptance among women and couples pertaining to the fertility preservation is a key catalyst for the growth of the market.
   
• Many organizations are undertaking several awareness programs to educate the women and couples regarding the advantages offered by the fertility preservation. For instance, the University of California, San Francisco (UCSF) run a campaign entitled Egg Freezing Program, which provides a support and education to the women considering fertility preservation, ensuring them to understand the process and the long-term benefit associated with the egg freezing.
   
• Similarly, organization such as American Society for Reproductive Medicine (ASRM) highlights the importance of fertility preservation in the events such as National Fertility Awareness Week.
   
• Therefore, by stimulating the awareness regarding the benefits of egg freezing and embryo banking, these programs help to reduce the stigma and promote an open discussion on the fertility preservation, especially among the women postponing the childbirth due to medical or personal reasons, thereby accelerating the adoption of these services among the women, fostering the market growth.
   

Egg Freezing and Embryo Banking Market Analysis

Based on service type, the market is divided into egg freezing and embryo banking. The global market was estimated at USD 4.3 billion in 2023. The embryo banking segment held revenues of USD 2.5 billion in the year 2023 and the segment is poised for significant growth at a CAGR of 9.7% during the forecast period.
 

• Embryo banking is the process of freezing the embryo resulted through the process of in-vitro-fertilization (IVF), which is estimated to reach USD 32.9 billion by 2032, where the egg is retrieved from the women and fertilized with sperm under the laboratory conditions to form an embryo, followed by the cryopreservation and storage of the embryo for future use.
   
• The growth of the segment is highly attributed due to rising prevalence of infertility and the increasing number of individuals postponing the pregnancy due to the medical and professional reasons.
   
• Women undergoing treatment such as chemotherapy, pose a potential risk to their fertility. For instance, as per the estimates around 40% to 80% of women undergoing chemotherapy due to breast cancer may experience infertility as a side effect.
   
• Therefore, as the prevalence of infertility increase among the women undergoing cancer treatment, so does the need for fertility preservation such as embryo banking is on rise. For instance, according to the studies approximately, 5% to 41% of women in the U.S. in 2023 undergone fertility preservation including embryo freezing before the cancer treatment, thereby boosting the segment growth.
   

Based on storage duration, the egg freezing and embryo banking market is bifurcated into short-term storage and long-term storage. The short-term storage segment held a market share of 67.2% in 2023 and the market is predicted to grow at 9.6% CAGR during the forecast period.
 

• Short term storage allows for the temporary preservation of the eggs and embryo typically ranging from few months to a few years. This type of storage is predominantly opted by the couples and individuals undergoing fertility treatment  such as assisted reproductive technology (ART) procedures, particularly in vitro fertilization (IVF), fostering the growth of the segment.
   
• For instance, according to European Society of Human Reproduction and Embryology, more than 3 million ART cycles are performed annually across the world. Therefore, as the adoption of ART procedures expands so does the need for short term shortage.  
   
• Moreover, the expansion of the specialty clinics such as specialized storage facilities and fertility clinics is making short term storage option more accessible for the individuals and couples across the globe, thereby propelling the segment growth.
   

Based on technology, the egg freezing and embryo banking market is bifurcated into vitrification and slow freezing. The vitrification segment is growing robustly, with a 9.9% CAGR during the forecast period.
 

• The growth of this segment is owing to the success and survival rate of the frozen embryo and egg following the vitrification thawing process.
   
• For instance, as per the estimates around 90% of egg and embryo survive the vitrification thawing procedures. Moreover approximately 70% to 80% of the thawed eggs are successfully fertilize increasing the chances of pregnancy.
   
• Moreover, the rising prevalence of the cancer among the female population worldwide pushing women to preserve the fertility before undergoing treatment through the technological advanced methods such as vitrification.
   
• For instance, as per the data from the American Society of Clinical Oncology (ASCO), approximately 40% of the cancer diagnosed women of the age group 18 to 40 years utilize fertility preservation methodologies such as vitrification before undergoing the cancer therapies, thereby accelerating the segment growth.
   

Based on application, the egg freezing and embryo banking market is bifurcated into fertility preservation, donor egg/embryo programs, genetic screening, and oncofertility. The fertility preservation segment accounted for a share of 30.9% in 2023 and is expected to grow at a CAGR of 9.7% during the forecast period.
 

• The growth of the segment is primarily driven by the growing trend towards delayed childbearing due to the financial stability, career aspirations, and due to the personal choice of the women, fueling more individual to incline towards fertility preservation.
   
• Moreover, the rising prevalence of infertility coupled with lifestyle factors such as stress, obesity, among others as heighted the demand and awareness pertaining to the proactive fertility management.
   
• For instance, as per the data from the Indian Journal of Community Medicine, around 60 to 80 million couples suffer from infertility annually worldwide, among them 15 to 20 million couples resides in India, equivalent to 25% of the total infertility population. Thus, as the prevalence of infertility rises so does the need for advanced fertility preservation, thereby accelerating the segment growth.
   

Based on age group, the egg freezing and embryo banking market is bifurcated into under 30, 31 to 40, and over 41. The 31 to 40 segment accounted for a share of 45.6% in 2023.
 

• The women of this age group generally face a decline in the rate of fertility due to the age-related factors.
   
• For instance, according to the data from the American College of Obstetricians and Gynecologists (ACOG), the rate of fertility of a woman begins to decline in the early 30’s and with more prominent decrease at the age of 35.
   
• Therefore, major population of women of this age group opt to freeze their embryo and eggs in order to enhance their chance of conception in future, whether due to the delay in family planning or due other health related circumstances.
   

In 2023, the U.S. led the North American market, generated a revenue of about USD 1.7 billion.
 

• This growth is highly attributed due to the large U.S. corporation have started offering the egg freezing and embryo banking as an overall coverage to their employees as a part of the health benefit package.
   
• For instance, Facebook offer their women employees egg freezing as a part of their health benefit package. The company covers the cost of the procedure up to USD 20,000.
   
• Similarly, Google covers the cost of the procedure up to USD 75,000 per women employees. The company also provide extra coverage to other fertility related treatments, inclusive of invitro fertilization. Thus, these financial coverages push the women employees to undergo fertility preservation, in turn propelling the market growth in the country.
   

Europe: The egg freezing and embryo banking market in the UK is projected to grow significantly from 2024 to 2032.
 

• The increasing prevalence of cancer among the women population in the country, fueling the adoption of egg freezing and embryo banking among them due to the infertility risk associated with the cancer treatment such as chemotherapy.
   
• According to the data from the Cancer Research UK, each year 56,822 women are diagnosed form the breast cancer in the country.
   
• Therefore, as the prevalence of cancer continues to expand so does need for fertility preservation among the women undergoing chemotherapy, thereby propelling the market growth in the country.
   

Asia Pacific: The egg freezing and embryo banking market in the Japan is projected to grow significantly from 2024 to 2032.
 

• Japan is forefront in the field of technological innovation, thus the ongoing development in the cryopreservation technologies, such ultra-rapid freezing, vitrification, among others are fueling the market growth and the adoption of these technologies among the fertility clinics, storage bank in the country.
   
• Moreover, rising public awareness regarding the egg freezing and embryo banking through the social media platforms as well as public campaigns fostering their adoption among the women population seeking fertility preservation services.
   

Middle East and Africa: The egg freezing and embryo banking market in the Saudi Arabia is projected to grow significantly from 2024 to 2032.
 

• In Saudi Arabia, there is a noticeable shift in societal norms, with more women delaying marriage and having children to focus on their careers or education. With an increased emphasis on personal growth and independence, many women are opting to freeze their eggs for future use.
   
• Thus, this growing trend is driving the market for egg freezing and embryo banking in the country.
   

Egg Freezing and Embryo Banking Market Share

The top 5 players of the market account for approximately 40% of the market share which includes companies such as Boston IVF, CCRM Fertility, Ovation Fertility, Progyny, Shady Grove Fertility, among others. Moreover, strategic partnerships with fertility clinics, hospitals, healthcare providers, research institutes, and government agencies play a key role in advancing the development of egg freezing and embryo banking technologies.
 

Moreover, the development of public awareness through the campaigns, social media platform is playing a crucial role in educating the individual regarding the fertility preservation options, boosting the adoption, and expanding the market reach, enabling market players to strengthen their position in this growing sector.
 

Egg Freezing and Embryo Banking Market Companies

Some of the eminent market participants operating in the egg freezing and embryo banking industry include:

• Boston IVF
• Carrot
• CCRM Fertility
• Cryos International
• Extend Fertility
• Genea Pty
• IVIRMA
• Monash IVF Group
• New Hope IVF & Fertility Clinic
• Ovation Fertility
• Progyny
• ReproTech
• RMA Network
• Shady Grove Fertility
• Spring Fertility
• WINFertility
   
• Boston IVF is one of the largest providers of IVF in the U.S., with over nine centers, 30 offices and 31 physicians across ten states.
   
• CCRM Fertility of Boston provides patient care and outcomes, with a dedicated on-site physician team, IVF laboratory, and comprehensive diagnostic services.
   

Egg Freezing and Embryo Banking Industry News:

• In November 2023, Spanish investment firm GED Capital and fertility group IVIRMA Global acquired the Barcelona-based fertility business Eugin Group in a deal valued at up to EUR 500 million (USD 558.4 million), including earn-outs. This acquisition enabled IVIRMA Global to further its expansion into the North American market.
   
• In June 2021, Boston IVF, a fertility clinic with over 25 locations across the U.S., announced a partnership with TMRW Life Sciences, Inc. to introduce innovative technology and automation to its cryostorage and fertility cell management practices. This integration of TMRW's groundbreaking innovations exemplifies Boston IVF's ongoing leadership in reproductive medicine. The partnership is expected to enhance operational efficiency, improve the accuracy of cryopreservation processes, and further solidify the clinic's position at the forefront of fertility treatment advancements.
   

The egg freezing and embryo banking market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Service Type

• Egg freezing
• Embryo banking

Market, By Storage Duration

• Short-term storage
• Long-term storage                      

Market, By Technology

• Vitrification
• Slow freezing

Market, By Application

• Fertility preservation
• Donor egg/embryo programs
• Genetic screening
• Oncofertility

Market, By Age Group

• Under 30 
• 31 to 40
• Over 41                 

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE